Vivos (RDGL) Net Cash Flow (2010 - 2025)
Vivos (RDGL) reported Net Cash Flow of -$540399.0 for Q4 2025, down 154.34% on a YoY basis from $994388.0 in Q4 2024, and down 17.87% sequentially from -$458481.0 in Q3 2025.
Vivos (RDGL) Net Cash Flow (2010 - 2025) Analysis & Trends
Vivos (RDGL) has 16 years of Net Cash Flow data on file, last reported at -$540399.0 in Q4 2025.
- For the quarter ending Q4 2025, Net Cash Flow fell 154.34% year-over-year to -$540399.0; the trailing twelve-month figure through Dec 2025 stood at -$550838.0 (down 188.81% YoY), and the FY2025 full-year result was -$654023.0, down 205.44% from the prior year.
- Net Cash Flow eased to -$540399.0 in Q4 2025, from -$458481.0 in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $1.6 million in Q1 2021 to a low of -$604510.0 in Q2 2025.
- A 5-year average of -$55633.0 and a median of -$282320.5 in 2022 frame the typical range for Net Cash Flow.
- Across the five-year window, Net Cash Flow soared 10558.09% in 2021 and sank 270.96% in 2025, its largest moves.
- Tracing RDGL's Net Cash Flow over 5 years: stood at -$380468.0 in 2021, then rose by 25.97% to -$281667.0 in 2022, then surged by 119.68% to $55443.0 in 2023, then jumped by 1693.53% to $994388.0 in 2024, then plunged by 154.34% to -$540399.0 in 2025.
- Business Quant data shows RDGL's Net Cash Flow at -$540399.0 in Q4 2025, -$458481.0 in Q3 2025, and -$604510.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -1.70 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -1.11 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -503.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -500.20 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 202.10 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -2.19 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -282.15 Mn |
| 10 | Vivos | 27.16 Mn | 25.60 Mn | -3,105.00 | -540,399.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -540,399.00 |
| Dec 31, 2025 | -540,399.00 |
| Sep 30, 2025 | -458,481.00 |
| Sep 30, 2025 | -458,481.00 |
| Jun 30, 2025 | -604,510.00 |
| Jun 30, 2025 | -604,510.00 |
| Mar 31, 2025 | 1.05 Mn |
| Mar 31, 2025 | 1.05 Mn |
| Dec 31, 2024 | 994,388.00 |
| Dec 31, 2024 | 994,388.00 |
| Sep 30, 2024 | -506,257.00 |
| Sep 30, 2024 | -506,257.00 |
| Jun 30, 2024 | 353,588.00 |
| Jun 30, 2024 | 353,588.00 |
| Mar 31, 2024 | -221,458.00 |
| Mar 31, 2024 | -221,458.00 |
| Dec 31, 2023 | 55,443.00 |
| Dec 31, 2023 | 55,443.00 |
| Sep 30, 2023 | -211,923.00 |
| Sep 30, 2023 | -211,923.00 |